Challenges for cysteamine stabilization, quantification, and biological effects improvement
The aminothiol cysteamine, derived from coenzyme A degradation in mammalian cells, presents several biological applications. However, the bitter taste and sickening odor, chemical instability, hygroscopicity, and poor pharmacokinetic profile of cysteamine limit its efficacy. The use of encapsulation...
Saved in:
Main Authors: | Carla Atallah (Author), Catherine Charcosset (Author), Hélène Greige-Gerges (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
by: Cristina Martín-Sabroso, et al.
Published: (2021) -
A Review on the Antimutagenic and Anticancer Effects of Cysteamine
by: Chun-Man Lee
Published: (2023) -
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
by: Ana Castro-Balado, et al.
Published: (2022) -
Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis
by: Anxo Fernández-Ferreiro, et al.
Published: (2017) -
Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients
by: Sabrina Klank, et al.
Published: (2023)